
Opinion|Videos|August 23, 2024
Biosimilar Utilization and Inventory Management
Author(s)Sophia Humphreys, PharmD, MHA
Sophia Humphreys, PharmD, MHA, BCBBS, discusses biosimilar utilization and inventory management.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How has the introduction of biosimilars affected the biologic landscape at specialty pharmacies, including the disease states treated and trends in utilization?
- What strategies, including the “just in time” inventory model, can specialty pharmacies employ to effectively manage their high-cost biologic and biosimilar inventory given the challenges of limited shelf space?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare's New GLP-1 Bridge Program: What Pharmacists Need to Know Before Dispensing
2
Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists
3
Isatuximab Wins FDA Approval, Becoming Second Subcutaneous Anti-CD38 for Multiple Myeloma
4
Single-Shot Respiratory Vaccine Could Transform Pharmacist Counseling and Immunization Rates
5







































































































